Trial Profile
A 5-day, Multicentre, Randomized, Open-label, Parallel Group, Active Control Pilot Study to Evaluate the Efficacy and Safety of OxyNorm (Oxycodone Hydrochloride Injection) in Comparison With Morphine Sulfate Through the IV Continuous Infusion Regimen in Patients With Cancer Pain
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2018
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary) ; Morphine
- Indications Cancer pain
- Focus Therapeutic Use
- Acronyms SWITCH
- Sponsors Mundipharma GmbH
- 26 Jul 2016 Status changed from recruiting to completed.
- 04 Feb 2016 New trial record